According to KYORIN Pharmaceutical's latest financial reports the company's current EPS (TTM) is $0.55. In 2022 the company made an earnings per share (EPS) of $0.78 an increase over its 2021 EPS that were of $0.63.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.55 | -29.53% |
2022 | $0.78 | 23.73% |
2021 | $0.63 | -38.86% |
2020 | $1.04 | 6.7% |
2019 | $0.97 | 32.8% |
2018 | $0.73 | -30.63% |
2017 | $1.05 | 13.15% |
2016 | $0.93 | -37.54% |
2015 | $1.49 | -0.06% |
2014 | $1.49 | -10.41% |
2013 | $1.67 | -8.64% |
2012 | $1.82 | 2.39% |
2011 | $1.78 | 27.51% |
2010 | $1.40 | 12.37% |
2009 | $1.24 |